No Prescription |
 |
 | ||
|
Comtan Generic Entacapone |
|
| ||
No Prescription » Prescription Drugs 4 » Comtan Generic Entacapone Product Origin: EU (Turkey) This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English. Medical Information: Entacapone (in-TACK-a-pohn)is used in combination with levodopa/carbidopa to treat Parkinson's disease sometimes referred to as shaking palsy. Some patients experience signs and symptoms of end-of-dose wearing-offö effect despite taking levodopa/carbidopa. Entacapone enhances the effect of levodopa/carbidopa. By improving muscle control this medicine allows more normal movements of the body. Comtan is used for Parkinson's disease. It is prescribed when doses of the combination drug levodopa/carbidopa (Sinemet) begin to wear off too soon. By extending the effect of each dose of Sinemet it frees the patient from the stiffness and tremors of Parkinson's for a longer period of time. Comtan works by inhibiting the effect of an enzyme that breaks down the levodopa in Sinemet. It has no effect on Parkinson's disease when used by itself.When used with levodopa and carbidopa entacapone increases levels of levodopa (Dopar Larodopa Sinemet) in the body. Entacapone is used with carbidopa and levodopa to treat patients with Parkinson's disease who experience the signs and symptoms of end-of-dose "wearing-off". Entacapone is used only in combination with carbidopa and levodopa. It has no effect if it is used on its own. Treating Parkinson disease when used with levodopa/carbidopa. Comtan is a catechol-o-methyltransferase (COMT) inhibitor. It works by increasing the levels of levodopa/carbidopa in the brain thereby enhancing its effectiveness. Buy Comtan Generic Entacapone and other Prescription Drugs 4 products online at Medstore. 3650
About Comtan Generic Entacapone: Product Type: Prescription Drugs 4 Comtan ( Generic Entacapone ) Comtan (Generic Entacapone) Generic Entacapone 200mg 100 Tablets Generic Entacapone Comtan
View more Prescription Drugs 4 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
